Dynavax Technologies Corp (DVAX)
11.42
-0.34
(-2.89%)
USD |
NASDAQ |
Apr 24, 16:00
11.42
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Gross Profit Margin (Quarterly): 84.37% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 84.37% |
| September 30, 2023 | 80.97% |
| June 30, 2023 | 77.53% |
| March 31, 2023 | 68.65% |
| December 31, 2022 | 58.00% |
| September 30, 2022 | 63.43% |
| June 30, 2022 | 67.49% |
| March 31, 2022 | 64.94% |
| December 31, 2021 | 62.06% |
| September 30, 2021 | 44.50% |
| June 30, 2021 | 71.87% |
| March 31, 2021 | 70.45% |
| Date | Value |
|---|---|
| December 31, 2020 | 79.24% |
| September 30, 2020 | 69.95% |
| June 30, 2020 | 56.18% |
| March 31, 2020 | 57.40% |
| December 31, 2019 | 55.25% |
| September 30, 2019 | 41.86% |
| June 30, 2019 | 46.54% |
| March 31, 2019 | 29.45% |
| December 31, 2018 | 25.74% |
| September 30, 2018 | -430.5% |
| June 30, 2018 | -496.1% |
| March 31, 2018 | -1.49K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
41.86%
Minimum
Sep 2019
84.37%
Maximum
Dec 2023
64.25%
Average
64.94%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | 88.06% |
| Ligand Pharmaceuticals Inc | 94.16% |
| Pacira BioSciences Inc | 73.69% |
| Esperion Therapeutics Inc | 64.49% |
| PetIQ Inc | 20.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.08% |
| Return on Assets | -0.66% |
| Return on Invested Capital | -0.79% |
| Profit Margin (Quarterly) | 0.39% |
| Operating Margin (Quarterly) | -15.27% |
| Return on Net Operating Assets | -2.80% |